Vladimir Anatolievich Chistyakov

Dr. Vladimir Anatolievich Chistyakov

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
RWRichard Weeks
Richard Weeks
DDDjamel Drider
Djamel Drider
VCVladimir Anatolievich Chistyakov
Vladimir Anatolievich Chistyakov
LDLeon Mt Dicks
Leon Mt Dicks

1 June 2011 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
VSV.P. Skulachev
V.P. Skulachev
YAY. N. Antonenko
Y. N. Antonenko
VAV. N. Anisimov
V. N. Anisimov
Boris V. ChernyakBoris V. Chernyak
Boris V. Chernyak
NDNikolay Denisov
Nikolay Denisov
VSV. P. Skulachev
V. P. Skulachev
Plastoquinone, a very effective electron carrier and antioxidant of chloroplasts, was conjugated with decyltriphenylphosphonium to obtain a cation easily penetrating through membranes. This cation, called SkQ1, is specifically targeted to mitochondria by electrophoresis in the electric field formed by the mitochondrial respiratory chain. The respiratory chain also regenerates reduced SkQ1H2 from its oxidized form that appears as a result of the antioxidant activity of SkQ1H2. SkQ1H2 prevents oxidation of cardiolipin, a mitochondrial phospholipid that is especially sensitive to attack by reactive oxygen species (ROS). In cell cultures, SkQ1 and its analog plastoquinonyl decylrhodamine 19 (SkQR1) arrest H2O2-induced apoptosis. When tested in vivo, SkQs (i) prolong the lifespan of fungi, crustaceans, insects, fish, and mice, (ii) suppress appearance of a large number of traits typical for age-related senescence (cataract, retinopathies, achromotrichia, osteoporosis, lordokyphosis, decline of the immune system, myeloid shift of blood cells, activation of apoptosis, induction of β-galactosidase, phosphorylation of H2AX histones, etc.) and (iii) lower tissue damage and save the lives of young animals after treatments resulting in kidney ischemia, rhabdomyolysis, heart attack, arrhythmia, and stroke. We suggest that the SkQs reduce mitochondrial ROS and, as a consequence, inhibit mitochondriamediated apoptosis, an obligatory step of execution of programs responsible for both senescence and fast “biochemical suicide” of an organism after a severe metabolic crisis.

3 February 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
EPEvgeniya Prazdnova
Evgeniya Prazdnova
Andrey V. GorovtsovAndrey V. Gorovtsov
Andrey V. Gorovtsov
NVNikita Gennadjevich Vasilchenko
Nikita Gennadjevich Vasilchenko
MKMaksim Kulikov
Maksim Kulikov
VSVarvara Statsenko
Varvara Statsenko
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
The modern paradigm assumes that interspecies communication of microorganisms occurs through precise regulatory mechanisms. In particular, antagonism between bacteria or bacteria and fungi can be achieved by direct destruction of the targeted cells through the regulated production of antimicrobial metabolites or by controlling their adaptive mechanisms, such as the formation of biofilms. The quorum-quenching phenomenon provides such a countermeasure strategy. This review discusses quorum-sensing suppression by Gram-positive microorganisms, the underlying mechanisms of this process, and its molecular intermediates. The main focus will be on Gram-positive bacteria that have practical applications, such as starter cultures for food fermentation, probiotics, and other microorganisms of biotechnological importance. The possible evolutionary role of quorum-quenching mechanisms during the development of interspecies interactions of bacteria is also considered. In addition, the review provides possible practical applications for these mechanisms, such as the control of pathogens, improving the efficiency of probiotics, and plant protection.

2 December 2016 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
AAAmmar R. Algburi
Ammar R. Algburi
SZSaskia Zehm
Saskia Zehm
VNVictoria Netrebov
Victoria Netrebov
ABAnzhelica B. Bren
Anzhelica B. Bren
VCVladimir Anatolievich Chistyakov
Vladimir Anatolievich Chistyakov
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas

13 December 2017 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
MMMaria S. Mazanko
Maria S. Mazanko
IGIvan Fiodorovich Gorlov
Ivan Fiodorovich Gorlov
EPEvgeniya V. Prazdnova
Evgeniya V. Prazdnova
MMMaxim S. Makarenko
Maxim S. Makarenko
AUAlexander V. Usatov
Alexander V. Usatov
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas

29 June 2021 in Animals
Verified
Journal Article
Open access
PDF file
IPIgor Popov
Igor Popov
AAAmmar R. Algburi
Ammar R. Algburi
EPEvgeniya Prazdnova
Evgeniya Prazdnova
MMMaria Sergeevna Mazanko
Maria Sergeevna Mazanko
Vladimir ElisashviliVladimir Elisashvili
Vladimir Elisashvili
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
One of the main problems in the poultry industry is the search for a viable replacement for antibiotic growth promoters. This issue requires a “one health” approach because the uncontrolled use of antibiotics in poultry can lead to the development of antimicrobial resistance, which is a concern not only in animals, but for humans as well. One of the promising ways to overcome this challenge is found in probiotics due to their wide range of features and mechanisms of action for health promotion. Moreover, spore-forming probiotics are suitable for use in the poultry industry because of their unique ability, encapsulation, granting them protection from the harshest conditions and resulting in improved availability for hosts’ organisms. This review summarizes the information on gastrointestinal tract microbiota of poultry and their interaction with commensal and probiotic spore-forming bacteria. One of the most important topics of this review is the absence of uniformity in spore-forming probiotic trials in poultry. In our opinion, this problem can be solved by the creation of standards and checklists for these kinds of trials such as those used for pre-clinical and clinical trials in human medicine. Last but not least, this review covers problems and challenges related to spore-forming probiotic manufacturing.